Patients Face Pandemic-Induced Tocilizumab Shortage

(MedPage Today) -- While the FDA's June authorization of tocilizumab (Actemra) for severe COVID-19 was a welcome development during a deadly pandemic, patients who rely on the medication for other conditions are now facing shortages.
Among the...